EP Patent

EP1434572B1 — Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques

Assigned to Flamel Ireland Ltd · Expires 2017-12-13 · 8y expired

What this patent protects

Patent listed against sodium-oxybate.

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

Patent Metadata

Patent number: EP1434572B1
Jurisdiction: EP
Classification: —
Expires: 2017-12-13
Drug substance claim: No
Drug product claim: No
Assignee: Flamel Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.